Delivery of tobramycin coupled to iron oxide nanoparticles across the biofilm of mucoidal Pseudonomas aeruginosa and investigation of its efficacy

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 8955, Issue , 2014, Pages

  Armijo, Leisha M ^a   Kopciuch, Michael ^a   Olszówka, Zuzia ^a,b   Wawrzyniec, Stephen J ^a   Rivera, Antonio C ^a   Plumley, John B ^a   Cook, Nathaniel C ^a   Brandt, Yekaterina I ^a   Huber, Dale L ^c   Smolyakov, Gennady A ^a   Adolphi, Natalie L ^d   Smyth, Hugh D C ^e   Osiński, Marek ^a,f  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b Albuquerque Institute for Math and Science   (United States)

^c SANDIA NATIONAL LABORATORIES   (United States)

^d UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^f UNIVERSIDAD CARLOS III DE MADRID   (Spain)

Author keywords

Antibiotic; Antibiotic sensitivities; Biofilm; Drug delivery; Ferrofluid; Magnetite; Nanoparticles; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTICS; BACTERIA; BIOFILMS; COLLOIDS; DRUG DELIVERY; IRON OXIDES; MAGNETITE; MAGNETITE NANOPARTICLES; MEDICAL APPLICATIONS; NANOMAGNETICS;

FERROFLUID; FUNCTIONALIZED NANOPARTICLES; IRON OXIDE NANOPARTICLE; OPPORTUNISTIC INFECTIONS; OSCILLATING MAGNETIC FIELDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS AERUGINOSA BACTERIA; SHORT-CHAIN CARBOXYLIC ACIDS;

NANOPARTICLES;

EID: 84901625689     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.2043340     Document Type: Conference Paper

References (38)

1. D. An and M. R. Parsek, "The promise and peril of transcriptional profiling in biofilm communities", Curr. Opin. Microbiol., vol. 10 (#3), pp. 292-296, June 2007.
2. L. M. Armijo, Y. I. Brandt, D. Mathew, S. Yadav, S. Maestas, A. C. Rivera, N. C. Cook, N. J. Withers, G. A. Smolyakov, N. L. Adolphi, T. C. Monson, D. L. Huber, H. D. C. Smyth, and M. Osiski, "Iron oxide nanocrystals for magnetic hyperthermia applications", Nanomater., vol. 2 (#2), pp. 134-146, 7 May 2012.
3. A. L. Baltch and R. P. Smith, Pseudomonas aeruginosa Infections and Treatment, Taylor & Francis, June 1994.
4. Y. P. Bao and K. M. Krishnan, "Preparation of functionalized and gold-coated cobalt nanocrystals for biomedical applications", J. Magnetism & Magnetic Mater., vol. 293, pp. 15-19, 2005.
5. U. Bezeljak, A. Golob, M. Jerala, L. Kandunc, Z. Lužnik, F. Pavlovec, B. Pirš, M. Somrak, M. Stražar, D. Vuko, U. Zupani, M. Benina, V. Forstneri, T. Lebar, A. Majerle, A. Oblak, R. Gaber, J. Lonzari, M. Mraz, M. Moškon, A. Smole, and R. Jerala, Switch IT. Inducible Therapeutics, iGEM 2012 Synthetic Biology Jamboree, http://2012. igem. org/wiki/index. phptitle=Team:Slovenia/ SafetyMechanismsMicrocapsuleDegradation&oldid=290454, accessed 12 Jan. 2014.
6. L. M. Bronstein, X. L. Huang, J. Retrum, A. Schmucker, M. Pink, B. D. Stein, and B. Dragnea., "Influence of iron oleate complex structure on iron oxide nanoparticle formation", Chem. Mater., vol. 19 (#15), pp. 3624-3632, 2007.
7. M. Campa, M. Bendinelli, and H. Friedman, Pseudomonas aeruginosa as an Opportunistic Pathogen, Plenum Press, New York 1993.
8. J. Connolly, T. G. St. Pierre, M. Rutnakornpituk, and J. S. Riffle, "Silica coating of cobalt nanoparticles increases their magnetic and chemical stability for biomedical applications", European Cells and Materials, vol. 3 (Suppl. 2), pp. 106-109, 2002.
9. J. A. Disegi, R. L. Kennedy, and R. Pilliar, Eds., Cobalt-Base Alloys for Biomedical Applications, Norfolk, VA, 3-4 Nov. 1998, ASTM Selected Technical Papers, vol. 1365, ASTM International, West Conshohocken, PA, Oct. 1999.
10. E. Duguet, S. Vasseur, S. Mornet, and J.-M. Devoisselle, "Magnetic nanoparticles and their applications in medicine", Nanomedicine, vol. 1 (#2) pp. 157-168, Aug. 2006.
11. R. B. Fick, Jr., Pseudomonas aeruginosa the Opportunist: Pathogenesis and Disease, CRC Press, Boca Raton, FL, Dec. 1992.
12. J.-P. Fortin, F. Gazeau, and C. Wilhelm, "Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles", Eur. Biophys. J., vol. 37 (#2), pp. 223-228, Feb. 2008.
13. P. Gacesa and N. J. Russell, "The Structure and Properties of Alginate", in Pseudonomas Infection and Alginates: Biochemistry, Genetics, and Pathology (P. Gacesa and N. J. Russell, Eds. ), Ch. 3, pp. 29-49, Chapman and Hall, London, 1990.
14. P. H. Gilligan, "Microbiology of airway disease in patients with cystic fibrosis", Clin. Microbiol. Rev., vol. 4 (#1), pp. 35-51, Jan. 1991.
15. J. R. W. Govan and V. Deretic, "Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia", Microbiol. Rev., vol. 60 (#3), pp. 539-574, Sept. 1996.
16. A. K. Gupta and M. Gupta, "Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications", Biomater., vol. 26 (#18), pp. 3995-4021, June 2005.
17. A. R. Hauser and J. Rello, Severe Infections Caused by Pseudomonas aeruginosa, Springer, London, March 2003.
18. G. T. Hermanson, Bioconjugate Techniques, 2nd Ed., Academic Press, San Diego, CA, 2008.
19. M. Johannsen, U. Gneveckow, K. Taymoorian, B. Thiesen, N. Waldöfner, R. Scholz, K. Jung, A. Jordan, P. Wust, and S. A. Loening, "Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial", Int. J. Hyperthermia, vol. 23 (#3), pp. 315-323, May 2007.
20. S. L. McGill, C. Cuylear, N. L. Adolphi, M. Osiski, and H. Smyth, "Enhanced drug transport through alginate biofilms using magnetic nanoparticles", Colloidal Quantum Dots for Biomedical Applications IV (M. Osiski, T. M. Jovin, and K. Yamamoto
21. SPIE International Symp. on Biomedical Optics BiOS 2009, San Jose, CA, 24-26 Jan. 2009, Proc. SPIE, vol. 7189, Paper 718918 (8 pp. ).
22. S. L. McGill, C. L. Cuylear, N. L. Adolphi, M. Osiski, and H. D. Smyth, "Magnetically responsive nanoparticles for drug delivery applications using low magnetic field strengths", IEEE Trans. NanoBioscience, vol. 8 (#1), pp. 33-42, March 2009.
23. F. Meiser, C. Cortez, and F. Caruso, "Biofunctionalization of fluorescent rareéarth-doped lanthanum phosphate colloidal nanoparticles", Angew. Chem. Int. Ed., vol. 43 (#44), pp. 5954-5957, 12 Nov. 2004.
24. D. J. Musk, D. A. Banko, and P. J. Hergenrother, "Iron salts perturb biofilm formation and disrupt existing biofilms of Pseudomonas aeruginosa", Chem. Biol., vol. 12 (#7), pp. 789-796, July 2005.
25. J. N. Park, K. J. An, Y. S. Hwang, J.-G. Park, H.-J. Noh, J.-Y. Kim, J.-H. Park, N.-M. Hwang, and T. G. Hyeon, "Ultra-large-scale syntheses of monodisperse nanocrystals", Nat. Mater., vol. 3 (#12), pp. 891-895, Dec. 2004.
26. P. Pradhan, J. Giri, G. Samanta, H. Dev Sarma, K. Prasad Mishra, J. Bellare, R. Banerjee, and D. Bahadur, "Comparative evaluation of heating ability and biocompatibility of different ferrite-based magnetic fluids for hyperthermia application", J. Biomed. Mater. Res. B-Appl. Biomater., vol. 81B (#1), pp. 12-22, April 2007.
27. Y. Qiang, J. Antony, A. Sharma, J. Nutting, D. Sikes, and D. Meyer, "Iron/iron oxide core-shell nanoclusters for biomedical applications", J. Nanoparticle Res., vol. 8 (#3-4), pp. 489-496, 2006.
28. K. N. Raymond and V. C. Pierre, "Next generation, high relaxivity gadolinium MRI agents", Bioconjug. e Chem., vol. 16 (#1), pp. 3-8, Jan.-Feb. 2005.
29. N. N. Sanders, S. C. De Smedt, E. Van Rompaey, P. Simoens, F. De Baets, and J. Demeester, "Cystic fibrosis sputum: A barrier to the transport of nanospheres", Am. J. Respir. Crit. Care Med., vol. 162 (#5), pp. 1905-1911, Nov. 2000.
30. E. V. Shtykova, A. Malyutin, J. Dyke, B. Stein, P. V. Konarev, B. Dragnea, D. I. Svergun, and L. M. Bronstein, "Hydrophilization of magnetic nanoparticles with modified alternating copolymers. Pt. 2: Behavior in solution", J. Phys. Chem. C: Nanometer Interfaces, vol. 114 (#50), pp. 21908-21913, 23 Dec. 2010.
31. C. F. Sio, L. G. Otten, R. H. Cool, S. P. Diggle, P. G. Braun, R. Bos, M. Daykin, M. Cámara, P. Williams, and W. J. Quax, "Quorum quenching by an N-acyl-homoserine lactone acylase from Pseudonomas aeruginosa PAO1", Infect. Immunol., vol. 74 (#3), pp. 1673-1682, March 2006.
32. R. S. Smith, S. G. Harris, R. Phipps, and B. Iglewski, "The Pseudonomas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)homoserine lactone contributes to virulence and induces inflammation in vivo", J. Bacteriol., vol. 184 (#4), pp. 1132-1139, Feb. 2002.
33. S. Vasseur, E. Duguet, J. Portier, G. Goglio, S. Mornet, E. Hadová, K. Knížek, M. Maryško, P. Veverka, and E. Pollert, "Lanthanum manganese perovskite nanoparticles as possible in vivo mediators for magnetic hyperthermia", J. Magnetism & Magnetic Mater., vol. 302 (#2), pp. 315-320, July 2006.
34. M. Whiteley, M. G. Bangera, R. E. Bumgarner, M. R. Parsek, G. M. Teitzel, S. Lory, and E. P. Greenberg, "Gene expression in Pseudomonas aeruginosa biofilms", Nature, vol. 413 (#6858), pp. 860-864, 25 Oct. 2001.
35. D. Worlitzsch, R. Tarran, M. Ulrich, U. Schwab, A. Cekici, K. C. Meyer, P. Birrer, G. Bellon, J. Berger, T. Weiss, K. Botzenhart, J. R. Yankaskas, S. Randell, R. C. Boucher, and G. Döring, "Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients", J. Clin. Invest., vol. 109 (#3), pp. 317-325, Feb. 2002.
36. P. Wust, U. Gneveckow, M. Johannsen, D. Böhmer, T. Henkel, F. Kahmann, J. Sehouli, R. Felix, J. Ricke, and A. Jordan, "Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures", Int. J. Hyperthermia, vol. 22 (#8), pp. 673-685, Dec. 2006.
37. J. Xie, S. Peng, N. Brower, N. Pourmand, S. X. Wang, and S. H. Sun, "One-pot synthesis of monodisperse iron oxide nanoparticles for potential biomedical applications", Pure Appl. Chem., vol. 78 (#5), pp. 1003-1014, 2006.
38. J. Xie, J. Huang, X. Li, S. Sun, and X. Chen, "Iron oxide nanoparticle platform for biomedical applications", Curr. Med. Chem., vol. 16 (#10), pp. 1278-1294, 2009.